P1018: UPDATED RESULTS FROM MANIFEST ARM 2: EFFICACY AND SAFETY OF PELABRESIB (CPI-0610) AS ADD-ON TO RUXOLITINIB IN MYELOFIBROSIS

por Kremyanskaya, Marina, Harrison, Claire, Bose, Prithviraj, Gupta, Vikas, Rampal, Raajit K, Lambert, Jonathan, Talpaz, Moshe, Vannucchi, Alessandro, Kuykendall, Andrew, Kiladjian, Jean-Jacques, Verstovsek, Srdan, Mesa, Ruben, Colak, Gozde, Klein, Sandra, Alvero, Carmelita, Mascarenhas, John
Publicado 2023

Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents

por Chandasana, Hardik, Thapar, Mita, Hayes, Siobhan, Baker, Mark, Gibb, Diana M., Turkova, Anna, Ford, Deborah, Ruel, Theodore, Wiznia, Andrew, Fairlie, Lee, Bwakura-Dangarembizi, Mutsa, Mujuru, Hilda, Alvero, Carmelita, Farhad, Mona, Hazra, Rohan, Townley, Ellen, Buchanan, Ann, Bollen, Pauline, Waalewijn, Hylke, Colbers, Angela, Burger, David, Acosta, Edward P., Singh, Rajendra
Publicado 2023

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age

por MacBrayne, Christine E., Rutstein, Richard M., Wiznia, Andrew A., Graham, Bobbie, Alvero, Carmelita G., Fairlie, Lee, Lypen, Kathryn, George, Kathleen H., Townley, Ellen, Moye, Jack, Costello, Diane G., Reding, Christina A., Barroso Hofer, Cristina, Crauwels, Herta M., Woot de Trixhe, Xavier, Tambuyzer, Lotke, Vanveggel, Simon, Opsomer, Magda, Kiser, Jennifer J.
Publicado 2021